The leading theory about what causes long COVID may need a major revision. A new neuroimaging study from Finland found no widespread brain inflammation in patients suffering persistent symptoms after COVID-19 infection, challenging a hypothesis that has dominated the field.
Instead, the research points to a different mechanism entirely. Patients with the most severe long COVID symptoms showed heightened activity in brain regions governing emotion, stress processing, and memory formation. The finding suggests that emotional and psychological factors may play a larger role in symptom severity than previously believed.
For years, scientists have suspected that SARS-CoV-2 leaves a trail of inflammation throughout the brain, explaining why long COVID patients struggle with fatigue, brain fog, anxiety, and depression. But direct evidence has remained elusive. The Finnish team set out to test this assumption using some of medicine's most advanced tools.
Researchers at the University of Turku scanned the brains of 14 long COVID patients, 11 healthy volunteers, and 13 people with multiple sclerosis, a disease known to cause significant brain inflammation. They used PET scans specifically designed to detect neuroinflammation, combined with MRI imaging to assess brain structure and white matter integrity. Blood samples were also analyzed for markers of neuronal damage.
The results were striking. Long COVID patients showed far less inflammatory activity in white matter compared to the MS group. When researchers looked at markers of brain inflammation and degeneration, they found no meaningful differences between long COVID patients and healthy controls.
One pattern did emerge, however. Among the long COVID group, those scanned within 16 months of infection showed higher levels of white matter inflammation than patients further removed from their original illness. This suggests inflammation may spike early in the disease but gradually fade, rather than persisting as a chronic problem.
The study uncovered something unexpected happening in different brain regions. Patients reporting higher anxiety, depression, and lower quality of life displayed increased activity in the hippocampus and amygdala, areas critical for emotional regulation and memory. This correlation held across the patient group, suggesting that emotional disturbances may be connected to how severely long COVID manifests in individual patients.
The implications for treatment could be substantial. If brain inflammation isn't the primary driver of symptoms in many long COVID cases, then anti-inflammatory therapies alone may prove insufficient. Instead, interventions targeting stress management and emotional health might offer more benefit for some patients.
Professor Laura Airas, who led the research, acknowledged the complexity. "This study highlights the need to continue investigating the complex biological mechanisms underlying long COVID. Understanding these processes is essential for developing targeted treatments," she stated.
The work appears in the Journal of Neurology and represents a significant departure from prevailing assumptions. While previous studies of severe acute COVID-19 did find brain inflammation, those findings may not apply uniformly to the long COVID population. The new evidence suggests the condition may be far more heterogeneous than previously thought, with different patients potentially experiencing different underlying pathologies.
Author Jessica Williams: "This study should shake up how we think about long COVID treatment, but the real work is just beginning. If inflammation isn't the main driver for most patients, we've been barking up the wrong tree."
Comments